Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Efficacy of N-Acetyl-Cysteine in Bipolar Disorder and Tobacco Use Disorder [Phase 4]
Phase 4 study evaluating the efficacy of N-acetylcysteine for bipolar disorder and tobacco use disorder. The current registry status is unkn…
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
The VA-sponsored CSP #572 study on genetics of functional disability in schizophrenia and bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.
A completed clinical trial update analyzing adherence to antipsychotic medications in patients admitted for acute psychosis by measuring ser…
-
FDA approval · 2015-04-13FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ziprasidone submitted by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Emotion Regulation Group Therapy for Bipolar Disorder [NA]
This clinical trial update reports the completion of a study evaluating Emotion Regulation Group Therapy for Bipolar I Disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: Bipolar Disorder Research Study for Ages 12 and Older [NA]
A completed clinical trial update for a bipolar disorder study involving participants aged 12 and older.
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: MAPS Group Therapy Model for Bipolar Disorder [NA]
This clinical trial update notes that the MAPS Group Therapy Model trial for bipolar disorder has completed (status: COMPLETED). No trial re…
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Psychiatric Advance Directives for Improved Mental Health Care [NA]
This update reports on a completed VA-sponsored clinical trial evaluating psychiatric advance directives to improve mental health care for i…
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Improving Antipsychotic Adherence Among Patients With Serious Mental Illness [NA]
A completed clinical trial update focusing on improving adherence to antipsychotic therapy among people with serious mental illness.
-
CLINICAL_TRIALS withdrawal · 2015-03-31Clinical Trial Update: Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence [Phase 2]
A Phase 2 open-label trial of Depakote ER in patients with bipolar I/II depression and alcohol use disorder has been withdrawn from the stud…
-
FDA approval · 2015-03-24FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for LAMICTAL XR (lamotrigine) filed by GlaxoSmithKline LLC.
-
FDA approval · 2015-03-24FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL ODT (lamotrigine) from GlaxoSmithKline LLC. The action indicates an approved change to …
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Virtual Darkness as Additive Treatment in Mania [NA]
A completed clinical trial evaluating virtual darkness as an additive treatment for mania in bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Early Integrated Intervention in Severe Affective Disorders [NA]
A clinical trial examining early integrated intervention for severe affective disorders has completed.
-
FDA approval · 2015-03-18FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for ziprasidone hydrochloride by Apotex Corp., approving the generic product under the ANDA.
-
FDA approval · 2015-03-17FDA Approved: RISPERIDONE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for risperidone by Ajanta Pharma USA Inc., expanding its regulatory clearance for additional indicat…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: eVAluatIon of OLanzapine TreatmEnT
A completed clinical trial evaluating olanzapine treatment in bipolar disorder and schizophrenia.
-
CLINICAL_TRIALS research · 2015-03-17Clinical Trial Update: Recognition and Early Intervention on Prodrome in Bipolar Disorders [NA]
This entry notes a clinical trial at Guangzhou Psychiatric Hospital investigating recognition and early intervention for prodromal symptoms …
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania [Phase 4]
A Phase 4 clinical trial update evaluating the comparative efficacy and acceptability of antimanic drugs for acute mania in bipolar disorder…
-
FDA approval · 2015-03-13FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental NDA for Depakote Sprinkles (divalproex sodium) from AbbVie, updating labeling and/or indications for the Spr…
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder [Phase 4]
Phase 4 clinical trial update reports results of varenicline for smoking cessation in patients with bipolar disorder, with results posted in…
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Lurasidone Extended Use Study [Phase 3]
This document reports the completion of a Phase 3 extended-use trial of lurasidone for schizophrenia and bipolar disorder, with results post…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898) [Phase 3]
Extension study of asenapine in pediatric bipolar disorder (Phase 3) has completed with results posted in 2015.
-
CLINICAL_TRIALS research · 2015-03-09Clinical Trial Update: Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder
AstraZeneca-sponsored clinical trial evaluating sub-syndromal symptoms after an acute depressive episode in bipolar disorder has been termin…
-
FDA approval · 2015-03-03FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA has approved Glenmark Pharmaceuticals Inc., USA's supplemental application for Lithium carbonate (generic) under ANDA 079139. The approv…